Slentiva

Help Take a Bite out of Hunger Pangs with Slentiva™

It happens every January. People make a New Year's resolution to commit to regular exercise and healthy eating. They’re pumped. They're motivated. But within a few days, hunger pangs eat into their resolve.

Sound familiar? Then try Slentiva, a delicious new dietary supplement that helps you to manage feelings of hunger. Scientifically-formulated Slentiva comes in a delicious chocolate chew that can help you feel fuller faster—and longer—with just one chew daily!

Fast and Easy Hunger Management

Through a patented process using potato protein extract, Slentiva’s proprietary active ingredient enhances satiety (feeling full or satisfied). This innovative approach to hunger management:

· influences the release of a natural satiety factor (cholecystokinin) associated with feeling full or satisfied

· helps promote a healthy glucose response when taken before a meal

Clinically Tested for Safety and Effectiveness

· 12 human clinical studies of the active ingredient support efficacy, with no reported serious adverse effects^1-12

· Contains no ephedrine, caffeine, or phenylpropranolamine

· Pleasing chocolate flavor

· Soft and easy to chew

· Click Here to order from Easy Health Zone

References

1. Dana, S. An open label phase II study of Satise^® for appetite control and weight loss. Kemin Consumer Care White Paper 2005. Kemin Industries, Inc.

2. Gutzwiller J-P, Drew J, Ketterer S, Hildebrand P, et al. A J Physiol Regulatory Integrative Comp Physiol 2005; 279:189-195.

3. Hill A, Peikin S, Ryan C, Blundell J. Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man. Physiol & Behav 1990;48:241-246.

4. Hu J, Edmonson B, Weitl S, Oaks L, Radosevich J. The effectiveness of potato proteinase inhibitor II (PI 2) in promoting satiety in human subject: glucose and insulin data summary. Kemin Consumer Care White Paper 2004. Kemin Industries, Inc.

5. Hu J, Edmonson B, Radosevich J. The effectiveness of potato proteinase inhibitor II in promoting satiety in healthy human subjects: vas data summary. Kemin Consumer Care L.C. White Paper 2004. Kemin Industries, Inc.

6. Hu J, Louie M, Dana S, Moore M, Edmondson B, Radosevich J. The effectiveness of potato proteinase inhibitor II in promoting satiety in healthy human subjects: cholecystokinin data. Kemin Consumer Care, L.C. White Paper 2005. Kemin Industries, Inc.

7. Hu J, Shao A, Dana S, Edmonson B, Radosvich J. The efficacy of potato proteinase inhibitor II in promoting weight loss in adults: a meta-analysis of clinical studies. Kemin Consumer Care White Paper, L.C. 2005. Kemin Industries, Inc.

8. Liddle R, Rushakoff J, Morita E, Beccaria L, Carter J, Goldfine D. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. J Clin Invest 1988. 81:1675-1681.

9. Phillips W, Schwartz J. Decelerating gastric emptying: therapeutic possibilities in type 2 diabetes. Diabet Med 1996;13(9 Suppl 5):S44-S48.

10. Schwartz J, Guan D. Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients. Diabetes Care 1994;17(4);255-262.

11. Spiegel TA, Hubert C, Peikin S. Effect of a pre-meal beverage containing a protease inhibitor from potatoes on satiety in dieting overweight women (Unpublished abstract, 1999). Presented at the North American Association for the Study of Obesity (NAASO) Annual Meeting, University of Medicine and Dentistry of New Jersey.

12. Spreadbury D, Shao A, Essmann M, Sheabar F, Geletta S, Larsen B. A proteinase inhibitor extract from potatoes reduces post-prandial blood glucose in human subjects. Journ Am Nutr Assoc 2003;6(1);29-38.

These statements have not been evaluated by the Food and Drug Administration.